CA2405273A1 - Procedes et dispositif d'endarteriectomie percutanee a distance - Google Patents

Procedes et dispositif d'endarteriectomie percutanee a distance Download PDF

Info

Publication number: CA2405273A1
Authority: CA; Canada
Prior art keywords: layer; intimal; stripping; adventitial; catheter
Prior art date: 2000-04-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002405273A

Other languages

English (en)

Inventor

Michael A. Evans

Denise M. Demarais

Gwendolyn A. Watanabe

Stephen A. Leeflang

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bacchus Vascular Inc

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-07

Filing date

2001-04-09

Publication date

2001-10-18

2001-03-27 Priority claimed from US09/820,084 external-priority patent/US7517352B2/en

2001-04-09 Application filed by Individual filed Critical Individual

2001-10-18 Publication of CA2405273A1 publication Critical patent/CA2405273A1/fr

Status Abandoned legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 104
238000013171 endarterectomy Methods 0.000 title abstract description 14
239000000463 material Substances 0.000 claims abstract description 73
210000004204 blood vessel Anatomy 0.000 claims abstract description 61
238000002224 dissection Methods 0.000 claims description 107
239000000853 adhesive Substances 0.000 claims description 58
230000001070 adhesive effect Effects 0.000 claims description 58
238000004873 anchoring Methods 0.000 claims description 13
238000012800 visualization Methods 0.000 claims description 11
238000003776 cleavage reaction Methods 0.000 claims description 10
230000007017 scission Effects 0.000 claims description 10
230000002879 macerating effect Effects 0.000 claims description 8
230000008569 process Effects 0.000 claims description 8
230000009471 action Effects 0.000 claims description 7
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 5
230000032798 delamination Effects 0.000 claims description 5
239000011780 sodium chloride Substances 0.000 claims description 5
102000008186 Collagen Human genes 0.000 claims description 3
108010035532 Collagen Proteins 0.000 claims description 3
229920001651 Cyanoacrylate Polymers 0.000 claims description 3
239000004593 Epoxy Substances 0.000 claims description 3
MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 claims description 3
239000000227 bioadhesive Substances 0.000 claims description 3
229920001436 collagen Polymers 0.000 claims description 3
238000002803 maceration Methods 0.000 abstract description 11
230000008901 benefit Effects 0.000 abstract description 9
238000013459 approach Methods 0.000 abstract description 5
230000000414 obstructive effect Effects 0.000 abstract description 3
230000004087 circulation Effects 0.000 abstract description 2
230000002093 peripheral effect Effects 0.000 abstract description 2
210000005166 vasculature Anatomy 0.000 abstract description 2
238000011282 treatment Methods 0.000 description 17
239000003795 chemical substances by application Substances 0.000 description 13
210000001519 tissue Anatomy 0.000 description 13
230000033001 locomotion Effects 0.000 description 8
208000007536 Thrombosis Diseases 0.000 description 7
101710110315 Bacchus Proteins 0.000 description 5
-1 tPA Proteins 0.000 description 5
AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 4
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 4
239000013256 coordination polymer Substances 0.000 description 4
230000003902 lesion Effects 0.000 description 4
230000035755 proliferation Effects 0.000 description 4
238000000926 separation method Methods 0.000 description 4
210000002460 smooth muscle Anatomy 0.000 description 4
206010003210 Arteriosclerosis Diseases 0.000 description 3
208000037260 Atherosclerotic Plaque Diseases 0.000 description 3
239000008280 blood Substances 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
210000004556 brain Anatomy 0.000 description 3
239000012530 fluid Substances 0.000 description 3
229910001000 nickel titanium Inorganic materials 0.000 description 3
208000037803 restenosis Diseases 0.000 description 3
IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
108010056764 Eptifibatide Proteins 0.000 description 2
102000009123 Fibrin Human genes 0.000 description 2
108010073385 Fibrin Proteins 0.000 description 2
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
206010028980 Neoplasm Diseases 0.000 description 2
MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
229910000639 Spring steel Inorganic materials 0.000 description 2
108010023197 Streptokinase Proteins 0.000 description 2
108010039185 Tenecteplase Proteins 0.000 description 2
108090000373 Tissue Plasminogen Activator Proteins 0.000 description 2
102000003978 Tissue Plasminogen Activator Human genes 0.000 description 2
238000005299 abrasion Methods 0.000 description 2
239000003146 anticoagulant agent Substances 0.000 description 2
229940127218 antiplatelet drug Drugs 0.000 description 2
239000004019 antithrombin Substances 0.000 description 2
210000001367 artery Anatomy 0.000 description 2
210000001715 carotid artery Anatomy 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
230000006378 damage Effects 0.000 description 2
239000003814 drug Substances 0.000 description 2
CZKPOZZJODAYPZ-LROMGURASA-N eptifibatide Chemical compound N1C(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCCNC(=N)N)NC(=O)CCSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]1CC1=CNC2=CC=CC=C12 CZKPOZZJODAYPZ-LROMGURASA-N 0.000 description 2
229950003499 fibrin Drugs 0.000 description 2
239000012634 fragment Substances 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
239000007788 liquid Substances 0.000 description 2
230000005012 migration Effects 0.000 description 2
238000013508 migration Methods 0.000 description 2
HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 2
238000004806 packaging method and process Methods 0.000 description 2
239000000106 platelet aggregation inhibitor Substances 0.000 description 2
229940107685 reopro Drugs 0.000 description 2
108010051412 reteplase Proteins 0.000 description 2
239000000126 substance Substances 0.000 description 2
238000001356 surgical procedure Methods 0.000 description 2
COKMIXFXJJXBQG-NRFANRHFSA-N tirofiban Chemical compound C1=CC(C[C@H](NS(=O)(=O)CCCC)C(O)=O)=CC=C1OCCCCC1CCNCC1 COKMIXFXJJXBQG-NRFANRHFSA-N 0.000 description 2
230000002792 vascular Effects 0.000 description 2
KWPACVJPAFGBEQ-IKGGRYGDSA-N (2s)-1-[(2r)-2-amino-3-phenylpropanoyl]-n-[(3s)-1-chloro-6-(diaminomethylideneamino)-2-oxohexan-3-yl]pyrrolidine-2-carboxamide Chemical compound C([C@@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)CCl)C1=CC=CC=C1 KWPACVJPAFGBEQ-IKGGRYGDSA-N 0.000 description 1
PUDHBTGHUJUUFI-SCTWWAJVSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-n-[(2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2r)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-p Chemical compound C([C@H]1C(=O)N[C@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](N)CC=1C=C2C=CC=CC2=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)=O)C(C)C)C1=CC=C(O)C=C1 PUDHBTGHUJUUFI-SCTWWAJVSA-N 0.000 description 1
239000005541 ACE inhibitor Substances 0.000 description 1
101710129690 Angiotensin-converting enzyme inhibitor Proteins 0.000 description 1
108010058207 Anistreplase Proteins 0.000 description 1
IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 1
BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
101150076489 B gene Proteins 0.000 description 1
101710086378 Bradykinin-potentiating and C-type natriuretic peptides Proteins 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
229940127291 Calcium channel antagonist Drugs 0.000 description 1
108050006400 Cyclin Proteins 0.000 description 1
108010041308 Endothelial Growth Factors Proteins 0.000 description 1
108010049003 Fibrinogen Proteins 0.000 description 1
102000008946 Fibrinogen Human genes 0.000 description 1
229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
102000007625 Hirudins Human genes 0.000 description 1
108010007267 Hirudins Proteins 0.000 description 1
229910002651 NO3 Inorganic materials 0.000 description 1
NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
102000013566 Plasminogen Human genes 0.000 description 1
108010051456 Plasminogen Proteins 0.000 description 1
108010035030 Platelet Membrane Glycoprotein IIb Proteins 0.000 description 1
102000009339 Proliferating Cell Nuclear Antigen Human genes 0.000 description 1
102000001253 Protein Kinase Human genes 0.000 description 1
102000052575 Proto-Oncogene Human genes 0.000 description 1
108700020978 Proto-Oncogene Proteins 0.000 description 1
208000002847 Surgical Wound Diseases 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
108010009583 Transforming Growth Factors Proteins 0.000 description 1
102000009618 Transforming Growth Factors Human genes 0.000 description 1
108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
206010047139 Vasoconstriction Diseases 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 1
229960000446 abciximab Drugs 0.000 description 1
238000002679 ablation Methods 0.000 description 1
229960001138 acetylsalicylic acid Drugs 0.000 description 1
239000002253 acid Substances 0.000 description 1
229940099983 activase Drugs 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
210000000577 adipose tissue Anatomy 0.000 description 1
238000011360 adjunctive therapy Methods 0.000 description 1
229940009456 adriamycin Drugs 0.000 description 1
229940000279 aggrastat Drugs 0.000 description 1
229960003318 alteplase Drugs 0.000 description 1
230000033115 angiogenesis Effects 0.000 description 1
238000002399 angioplasty Methods 0.000 description 1
229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
239000002260 anti-inflammatory agent Substances 0.000 description 1
229940121363 anti-inflammatory agent Drugs 0.000 description 1
230000002785 anti-thrombosis Effects 0.000 description 1
239000003080 antimitotic agent Substances 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
229940090880 ardeparin Drugs 0.000 description 1
KXNPVXPOPUZYGB-XYVMCAHJSA-N argatroban Chemical compound OC(=O)[C@H]1C[C@H](C)CCN1C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C1=CC=CC2=C1NC[C@H](C)C2 KXNPVXPOPUZYGB-XYVMCAHJSA-N 0.000 description 1
229960003856 argatroban Drugs 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
210000000013 bile duct Anatomy 0.000 description 1
230000017531 blood circulation Effects 0.000 description 1
230000036772 blood pressure Effects 0.000 description 1
238000002725 brachytherapy Methods 0.000 description 1
210000005013 brain tissue Anatomy 0.000 description 1
230000009172 bursting Effects 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
238000013172 carotid endarterectomy Methods 0.000 description 1
230000008859 change Effects 0.000 description 1
229960001338 colchicine Drugs 0.000 description 1
239000002872 contrast media Substances 0.000 description 1
229940039231 contrast media Drugs 0.000 description 1
208000031513 cyst Diseases 0.000 description 1
229940127089 cytotoxic agent Drugs 0.000 description 1
229960004969 dalteparin Drugs 0.000 description 1
230000006735 deficit Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
229960004679 doxorubicin Drugs 0.000 description 1
230000000694 effects Effects 0.000 description 1
230000003073 embolic effect Effects 0.000 description 1
230000010102 embolization Effects 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
229960004468 eptifibatide Drugs 0.000 description 1
210000003238 esophagus Anatomy 0.000 description 1
229940012952 fibrinogen Drugs 0.000 description 1
238000013467 fragmentation Methods 0.000 description 1
238000006062 fragmentation reaction Methods 0.000 description 1
229940087051 fragmin Drugs 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 1
229940006607 hirudin Drugs 0.000 description 1
239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
229940125721 immunosuppressive agent Drugs 0.000 description 1
238000001802 infusion Methods 0.000 description 1
208000014674 injury Diseases 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
108010059557 kistrin Proteins 0.000 description 1
108010021336 lanreotide Proteins 0.000 description 1
229960002437 lanreotide Drugs 0.000 description 1
229940118179 lovenox Drugs 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
230000036210 malignancy Effects 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
239000012528 membrane Substances 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
230000014508 negative regulation of coagulation Effects 0.000 description 1
230000007971 neurological deficit Effects 0.000 description 1
210000003101 oviduct Anatomy 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
239000002831 pharmacologic agent Substances 0.000 description 1
229940096701 plain lipid modifying drug hmg coa reductase inhibitors Drugs 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
230000010118 platelet activation Effects 0.000 description 1
230000002265 prevention Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
108060006633 protein kinase Proteins 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
230000005855 radiation Effects 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
210000000664 rectum Anatomy 0.000 description 1
230000011514 reflex Effects 0.000 description 1
229940116243 retavase Drugs 0.000 description 1
229960002917 reteplase Drugs 0.000 description 1
ZTYNVDHJNRIRLL-FWZKYCSMSA-N rhodostomin Chemical compound C([C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N[C@@H]2C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CSSC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H](CC=2NC=NC=2)C(O)=O)[C@@H](C)O)=O)CSSC[C@H]2C(=O)N[C@H]3CSSC[C@@H](C(NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H]2NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)CN)CSSC2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2CCC[C@H]2C(=O)N[C@H](C(N4)=O)CSSC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC3=O)C(=O)N[C@@H](CCCCN)C(=O)N1)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=CC=C1 ZTYNVDHJNRIRLL-FWZKYCSMSA-N 0.000 description 1
230000028327 secretion Effects 0.000 description 1
230000009919 sequestration Effects 0.000 description 1
229910001285 shape-memory alloy Inorganic materials 0.000 description 1
230000003637 steroidlike Effects 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
229960005202 streptokinase Drugs 0.000 description 1
229960000216 tenecteplase Drugs 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
238000013151 thrombectomy Methods 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
230000002537 thrombolytic effect Effects 0.000 description 1
229960003425 tirofiban Drugs 0.000 description 1
229940113038 tnkase Drugs 0.000 description 1
210000004026 tunica intima Anatomy 0.000 description 1
210000000626 ureter Anatomy 0.000 description 1
210000004291 uterus Anatomy 0.000 description 1
230000025033 vasoconstriction Effects 0.000 description 1
229940124549 vasodilator Drugs 0.000 description 1
239000003071 vasodilator agent Substances 0.000 description 1
239000013603 viral vector Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/320725—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions with radially expandable cutting or abrading elements
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1027—Making of balloon catheters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M29/00—Dilators with or without means for introducing media, e.g. remedies
- A61M29/02—Dilators made of swellable material
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B17/221—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/32—Surgical cutting instruments
- A61B17/320016—Endoscopic cutting instruments, e.g. arthroscopes, resectoscopes
- A61B17/32002—Endoscopic cutting instruments, e.g. arthroscopes, resectoscopes with continuously rotating, oscillating or reciprocating cutting instruments
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/32075—Pullback cutting; combined forward and pullback cutting, e.g. with cutters at both sides of the plaque
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/320783—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions through side-hole, e.g. sliding or rotating cutter inside catheter
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/00234—Surgical instruments, devices or methods for minimally invasive surgery
- A61B2017/00287—Bags for minimally invasive surgery
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/00234—Surgical instruments, devices or methods for minimally invasive surgery
- A61B2017/00362—Packages or dispensers for MIS instruments
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/32—Surgical cutting instruments
- A61B2017/320004—Surgical cutting instruments abrasive
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/32—Surgical cutting instruments
- A61B2017/320044—Blunt dissectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B2017/320741—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions for stripping the intima or the internal plaque from a blood vessel, e.g. for endarterectomy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters
- A61M2025/1015—Multiple balloon catheters having two or more independently movable balloons where the distance between the balloons can be adjusted, e.g. two balloon catheters concentric to each other forming an adjustable multiple balloon catheter system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1088—Balloon catheters with special features or adapted for special applications having special surface characteristics depending on material properties or added substances, e.g. for reducing friction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/109—Balloon catheters with special features or adapted for special applications having balloons for removing solid matters, e.g. by grasping or scraping plaque, thrombus or other matters that obstruct the flow
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1002—Balloon catheters characterised by balloon shape

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Vascular Medicine (AREA)
Molecular Biology (AREA)
Medical Informatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Anesthesiology (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Child & Adolescent Psychology (AREA)
Biophysics (AREA)
Pulmonology (AREA)
Surgical Instruments (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)

CA002405273A 2000-04-07 2001-04-09 Procedes et dispositif d'endarteriectomie percutanee a distance Abandoned CA2405273A1 (fr)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US19565300P	2000-04-07	2000-04-07
US60/195,653		2000-04-07
US27410401P	2001-03-07	2001-03-07
US60/274,104		2001-03-07
US09/820,084 US7517352B2 (en)	2000-04-07	2001-03-27	Devices for percutaneous remote endarterectomy
US09/820,084		2001-03-27
PCT/US2001/011672 WO2001076458A2 (fr)	2000-04-07	2001-04-09	Procedes et dispositif d'endarteriectomie percutanee a distance

Publications (1)

Publication Number	Publication Date
CA2405273A1 true CA2405273A1 (fr)	2001-10-18

Family

ID=27393483

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002405273A Abandoned CA2405273A1 (fr)	2000-04-07	2001-04-09	Procedes et dispositif d'endarteriectomie percutanee a distance

Country Status (5)

Country	Link
EP (1)	EP1278467A2 (fr)
JP (1)	JP2004506454A (fr)
AU (1)	AU2001255302A1 (fr)
CA (1)	CA2405273A1 (fr)
WO (1)	WO2001076458A2 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7862575B2 (en)	2003-05-21	2011-01-04	Yale University	Vascular ablation apparatus and method
US7967834B2 (en)	2006-09-13	2011-06-28	Vascular Insights Llc	Vascular treatment device
US8696645B2 (en)	2010-11-15	2014-04-15	Vascular Insights Llc	Vascular treatment devices and methods

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7166120B2 (en)	2002-07-12	2007-01-23	Ev3 Inc.	Catheter with occluding cuff
JP4493608B2 (ja) *	2006-03-06	2010-06-30	テルモ株式会社	アテレクトミーカテーテル
WO2009063470A1 (fr) *	2007-11-14	2009-05-22	Medivur Ltd.	Cathéter chirugical endoluminal
US8192451B2 (en) *	2008-06-05	2012-06-05	Cardiovascular Systems, Inc.	Cutting and coring atherectomy device and method
US9848881B2 (en)	2012-05-09	2017-12-26	Fusion Medical, Inc.	Clot removal device for deep vein thrombosis
WO2015190575A1 (fr) *	2014-06-13	2015-12-17	テルモ株式会社	Dispositif médical et procédé de traitement
JP2017012670A (ja) *	2015-07-06	2017-01-19	オリンパス株式会社	処置具
EP3407809B1 (fr) *	2016-01-27	2021-12-29	Fusion Medical, Inc.	Dispositif de retrait de caillot pour vaisseaux sanguins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5356418A (en) *	1992-10-28	1994-10-18	Shturman Cardiology Systems, Inc.	Apparatus and method for rotational atherectomy

2001
- 2001-04-09 WO PCT/US2001/011672 patent/WO2001076458A2/fr not_active Ceased
- 2001-04-09 CA CA002405273A patent/CA2405273A1/fr not_active Abandoned
- 2001-04-09 JP JP2001573982A patent/JP2004506454A/ja active Pending
- 2001-04-09 AU AU2001255302A patent/AU2001255302A1/en not_active Abandoned
- 2001-04-09 EP EP01928445A patent/EP1278467A2/fr not_active Withdrawn

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7862575B2 (en)	2003-05-21	2011-01-04	Yale University	Vascular ablation apparatus and method
US8465508B2 (en)	2003-05-21	2013-06-18	Yale University	Vascular ablation apparatus and method
US7967834B2 (en)	2006-09-13	2011-06-28	Vascular Insights Llc	Vascular treatment device
US10463388B2 (en)	2006-09-13	2019-11-05	Merit Medical Systems, Inc.	Wire and device for vascular treatment
US11903608B2 (en)	2006-09-13	2024-02-20	Merit Medical Systems, Inc.	Wire and device for vascular treatment
US8696645B2 (en)	2010-11-15	2014-04-15	Vascular Insights Llc	Vascular treatment devices and methods
US9375216B2 (en)	2010-11-15	2016-06-28	Vascular Insights, Llc	Direction reversing vascular treatment device
US9585667B2 (en)	2010-11-15	2017-03-07	Vascular Insights Llc	Sclerotherapy catheter with lumen having wire rotated by motor and simultaneous withdrawal from vein
US11241250B2 (en)	2010-11-15	2022-02-08	Merit Medical Systems, Inc.	Vascular treatment devices and methods

Also Published As

Publication number	Publication date
EP1278467A2 (fr)	2003-01-29
AU2001255302A1 (en)	2001-10-23
WO2001076458A2 (fr)	2001-10-18
WO2001076458A3 (fr)	2002-03-28
JP2004506454A (ja)	2004-03-04

Legal Events

Date	Code	Title	Description
2006-03-03	EEER	Examination request
2009-04-09	FZDE	Dead

Publication	Publication Date	Title
US7517352B2 (en)	2009-04-14	Devices for percutaneous remote endarterectomy
CA2404144C (fr)	2013-02-19	Catheters cisaillants dilatables d'elimination des thrombus et des substances obstruantes
US5843103A (en)	1998-12-01	Shaped wire rotational atherectomy device
US8043314B2 (en)	2011-10-25	Guidewire for crossing occlusions or stenoses
CN101511285B (zh)	2012-07-18	动脉粥样硬化切除术装置和方法
JP2003507083A (ja)	2003-02-25	血管および／またはイン・ビボステントへのダメージを低減するための剥離装置
JPH03272754A (ja)	1991-12-04	カテーテル
CA2405273A1 (fr)	2001-10-18	Procedes et dispositif d'endarteriectomie percutanee a distance
JP2020508136A (ja)	2020-03-19	血栓および／または軟性プラークの除去のためのシステム、方法および装置
EP4322873B1 (fr)	2025-10-29	Cathéter d'ablation de tissu avec élément d'élimination de tissu ayant une face d'extrémité distale oblique
US12458393B2 (en)	2025-11-04	Rotary debulking atherectomy device with a crossing balloon
AU2001253035B2 (en)	2005-03-03	Expansible shearing catheters for thrombus and occlusive material removal
CA2488588C (fr)	2014-08-05	Fil-guide permettant de traverser des occlusions ou des stenoses
AU2001253035A1 (en)	2002-01-03	Expansible shearing catheters for thrombus and occlusive material removal
Arko et al.	2005	Catheter‐Based Approaches to the Treatment of Atheroembolic Disease